FDA Approved: REZZAYO — Original Application (Melinta Therapeutics, LLC)

View source ↗

Summary

FDA approved the original application for REZZAYO (rezafungin) by Melinta Therapeutics for the treatment of candidemia and invasive candidiasis in adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Candidemia
• Invasive Candidiasis

Drugs mentioned

• REZZAYO (REZAFUNGIN)

Snippet

ORIG AP for REZZAYO (REZAFUNGIN)